Flash | 06 Aug 2026 08:11:06 ET │ 12 pages Evolent Health (EVH.N) 2Q26 Quick Take: PS Growth and Opex Discipline Leads to Beat-and- Raise CITI'S TAKE EVH reported a solid quarter with revenue growing 47% y/y (beating our/cons. estimates by 3.1%/9.4%, driven predominantly by the Highmark launch on May 1, 2026 and significant Performance Suite (PS) expansion. PS revenue grew 81% y/y, beating our/cons. estimates by 5%/15%. The topline strength was partially offset by elevated medical costs (MER came in at 95.3 ...